Swiss - Delayed Quote CHF

Idorsia Ltd (IDIA.SW)

2.0000
0.0000
(0.00%)
At close: June 5 at 5:31:35 PM GMT+2
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
161,332
112,508
152,386
97,102
35,349
Cost of Revenue
34,837
35,926
7,150
6,266
0
Gross Profit
126,495
76,582
145,236
90,836
35,349
Operating Expense
392,279
413,837
688,290
893,800
648,353
Operating Income
-265,784
-337,255
-543,054
-802,964
-613,004
Net Non Operating Interest Income Expense
-33,528
-31,309
-39,107
-17,124
-21,802
Pretax Income
-229,819
-263,323
-294,253
-820,089
-634,805
Tax Provision
681
434
3,668
7,807
-210
Net Income Common Stockholders
-230,499
-263,757
-297,921
-827,896
-634,595
Diluted NI Available to Com Stockholders
-230,499
-263,757
-297,921
-827,896
-634,595
Basic EPS
-1.29
-1.45
-1.67
-4.67
-3.77
Diluted EPS
-1.35
-1.45
-1.67
-4.67
-3.77
Basic Average Shares
184,888.5000
182,447
178,247
177,433.9340
168,498.0480
Diluted Average Shares
191,820.5000
182,447
178,247
177,433.9340
168,498.0480
Total Operating Income as Reported
-196,290
-232,014
-255,145
-802,965
-613,004
Total Expenses
427,116
449,763
695,440
900,066
648,353
Net Income from Continuing & Discontinued Operation
-230,499
-263,757
-297,921
-827,896
-634,595
Normalized Income
-294,085.0950
-360,053.4300
-561,355.9050
-827,896
-634,595
Interest Expense
22,455
20,124
20,668
17,172
27,937
Net Interest Income
-33,528
-31,309
-39,107
-17,124
-21,802
EBIT
-207,364
-243,199
-273,585
-802,917
-606,868
EBITDA
-189,011
-225,332
-254,551
-783,088
-588,835
Reconciled Cost of Revenue
34,837
35,926
7,150
6,266
0
Reconciled Depreciation
18,353
17,867
19,034
19,829
18,033
Net Income from Continuing Operation Net Minority Interest
-230,499
-263,757
-297,921
-827,896
-634,595
Total Unusual Items Excluding Goodwill
69,493
105,242
287,907
0
--
Total Unusual Items
69,493
105,242
287,907
0
--
Normalized EBITDA
-258,504
-330,574
-542,458
-783,088
-588,835
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0
Tax Effect of Unusual Items
5,906.9050
8,945.5700
24,472.0950
0
0
12/31/2021 - 6/16/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SANN.SW Santhera Pharmaceuticals Holding AG
13.14
-0.15%
 
NWRN.SW Newron Pharmaceuticals S.p.A.
7.32
0.00%
 
RLF.SW Relief Therapeutics Holding SA
2.2100
-3.91%
 
MOLN.SW Molecular Partners AG
2.9500
-2.64%
 
BION.SW BB Biotech AG Ord
30.70
0.00%
 
EVE.SW Evolva Holding SA
1.1400
-2.56%
 
XLS.SW Xlife Sciences AG
19.50
-2.01%
 
BSLN.SW Basilea Pharmaceutica AG
49.20
+6.15%
 
MOLN Molecular Partners AG
3.5600
-2.47%
 
ACIU AC Immune SA
1.7300
+3.59%